These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24207125)

  • 41. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99.
    Lee XA; Verma C; Sim AYL
    Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interaction.
    Dezi C; Carotti A; Magnani M; Baroni M; Padova A; Cruciani G; Macchiarulo A; Pellicciari R
    J Chem Inf Model; 2010 Aug; 50(8):1451-65. PubMed ID: 20726601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction.
    Thayer KM; Beyer GA
    PLoS One; 2016; 11(3):e0147806. PubMed ID: 26992014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics.
    Verkhivker GM
    PLoS One; 2012; 7(7):e40897. PubMed ID: 22815859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.
    Ciemny MP; Debinski A; Paczkowska M; Kolinski A; Kurcinski M; Kmiecik S
    Sci Rep; 2016 Dec; 6():37532. PubMed ID: 27905468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models.
    Bowman AL; Nikolovska-Coleska Z; Zhong H; Wang S; Carlson HA
    J Am Chem Soc; 2007 Oct; 129(42):12809-14. PubMed ID: 17902662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument.
    Furet P; Masuya K; Kallen J; Stachyra-Valat T; Ruetz S; Guagnano V; Holzer P; Mah R; Stutz S; Vaupel A; Chène P; Jeay S; Schlapbach A
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4837-4841. PubMed ID: 27542305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rational design and binding mode duality of MDM2-p53 inhibitors.
    Gonzalez-Lopez de Turiso F; Sun D; Rew Y; Bartberger MD; Beck HP; Canon J; Chen A; Chow D; Correll TL; Huang X; Julian LD; Kayser F; Lo MC; Long AM; McMinn D; Oliner JD; Osgood T; Powers JP; Saiki AY; Schneider S; Shaffer P; Xiao SH; Yakowec P; Yan X; Ye Q; Yu D; Zhao X; Zhou J; Medina JC; Olson SH
    J Med Chem; 2013 May; 56(10):4053-70. PubMed ID: 23597064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
    Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
    Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.
    Czarna A; Popowicz GM; Pecak A; Wolf S; Dubin G; Holak TA
    Cell Cycle; 2009 Apr; 8(8):1176-84. PubMed ID: 19305137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2.
    Sakurai K; Schubert C; Kahne D
    J Am Chem Soc; 2006 Aug; 128(34):11000-1. PubMed ID: 16925398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated virtual screening and molecular dynamics simulation revealed promising drug candidates of p53-MDM2 interaction.
    Oyedele AK; Adelusi TI; Ogunlana AT; Adeyemi RO; Atanda OE; Babalola MO; Ashiru MA; Ayoola IJ; Boyenle ID
    J Mol Model; 2022 May; 28(6):142. PubMed ID: 35536362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A computational analysis of the binding model of MDM2 with inhibitors.
    Hu G; Wang D; Liu X; Zhang Q
    J Comput Aided Mol Des; 2010 Aug; 24(8):687-97. PubMed ID: 20490618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
    Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
    Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
    Shloush J; Vlassov JE; Engson I; Duan S; Saridakis V; Dhe-Paganon S; Raught B; Sheng Y; Arrowsmith CH
    J Biol Chem; 2011 Feb; 286(6):4796-808. PubMed ID: 21084285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-naturally Occurring Helical Molecules Can Interfere with p53-MDM2 and p53-MDMX Protein-Protein Interactions.
    Su A; Wang S; Sada A; Otani Y; Zhai L; Liu X; Sayama M; Ohki R; Ohwada T
    Chem Pharm Bull (Tokyo); 2019; 67(10):1139-1143. PubMed ID: 31582633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elucidation of Ligand-Dependent Modulation of Disorder-Order Transitions in the Oncoprotein MDM2.
    Bueren-Calabuig JA; Michel J
    PLoS Comput Biol; 2015 Jun; 11(6):e1004282. PubMed ID: 26046940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant.
    Anil B; Riedinger C; Endicott JA; Noble ME
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1358-66. PubMed ID: 23897459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization beyond AMG 232: discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein-protein interaction.
    Wang Y; Zhu J; Liu JJ; Chen X; Mihalic J; Deignan J; Yu M; Sun D; Kayser F; McGee LR; Lo MC; Chen A; Zhou J; Ye Q; Huang X; Long AM; Yakowec P; Oliner JD; Olson SH; Medina JC
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3782-5. PubMed ID: 25042256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100.
    Dastidar SG; Lane DP; Verma CS
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S6. PubMed ID: 19958516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.